ACE Cancer Research Exome

Using our patented ACE Technology, the ACE Cancer Research Exome outperforms conventional exome assays by augmenting coverage across intronic and difficult-to-sequence (high-GC content) regions, ensuring the capture of variants that would be otherwise missed. Key features: Even coverage across all exons (>20,000 genes) and enhanced coverage of >8,000 biomedically-important genes, including >1,400 cancer-related genes. Augmentation [...]